Medical Product Safety Alerts

A six-year study pitting the newer blood pressure drug Micardis with the ACE inhibitor ramipril found Micardis was just as… »   

Merck & Co said on Monday that patients on its experimental obesity drug lost more than twice as much weight… »   

New data about the controversial cholesterol fighter Vytorin failed to quell concerns that the drug might not be as good… »   

New data from a clinical trial using intravascular ultrasound (IVUS) technology found that in patients living with type 2 diabetes,… »   

New study shows that the use of powerful anticoagulants to prevent pulmonary embolism may actually lead to more deaths after… »   

A recently approved angina drug may also represent a powerful new treatment for a rare hereditary syndrome that places teens… »   

A major Canadian-led global study has found that a new blood pressure medication is effective in reducing cardiovascular death, with… »   

One of the world’s deadliest diseases, caused by the Ebola virus, may finally be preventable thanks to US and Canadian… »   

Supplies of the blood-thinning drug heparin are being recalled in France, Italy and Denmark because they are contaminated or suspected… »   

Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced today that the U.S. Food and Drug Administration (FDA) has approved… »   

Cephalon Inc won U.S. approval to sell a chemotherapy drug to treat patients with a slow-growing type of leukemia, the… »   

We analyzed data from 6341 injection drug users (IDUs) entering detoxification or methadone maintenance treatment in New York City between… »   

Researchers at the Joslin Diabetes Center have shown that insulin has a previously unknown effect that plays a role in… »   

Medtronic Inc said on Wednesday that U.S. regulators classified its move to inform physicians about an increase in the rate… »   

Belgian pharmaceutical group UCB said on Thursday it was recalling its Parkinson’s drug Neupro in the United States and some… »